Search

everythinglearnresearchcommunity

for

Search:↓

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

An 11-year-old child with total hair loss may have a genetic autoimmune disease, and the outlook for hair regrowth is not good.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

Some nutraceuticals may help in COVID-19 prevention and treatment, but more research is needed.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

Pimecrolimus cream is not effective for treating alopecia areata.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

Apoptosis is crucial for healthy skin and treating skin diseases.

17β-estradiol can reduce inflammation in the skin.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

Using defensins to activate stem cells may improve skin aging signs without causing inflammation.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Researchers found four genes that could help diagnose severe alopecia areata early.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

COVID-19 reinfection may trigger alopecia areata.

No cure exists for alopecia areata, and treatments are personalized.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

The meeting covered new findings in children's skin conditions and treatments, including the benefits of super absorbent polymer diapers.

The document concludes that understanding how the skin's immune system and inflammation work is complex and requires more research to improve treatments for skin diseases.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Dupilumab for eczema may cause hair loss.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.